Cardiovascular Journal of Africa: Vol 31 No 5 (September/October 2020)

20 / 64

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 5, September/October 2020 240 AFRICA
7. Lipshultz SE, Easley KA, Orav EJ, et al. Cardiac dysfunction and
mortality in HIV-infected children: The Prospective P2C2 HIV
Multicenter Study. Pediatric Pulmonary and Cardiac Complications
of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.
Circulation 2000; 102: 1542–1548.
8. Lipshultz SE, Easley KA, Orav EJ, et al. Pediatric Pulmonary and
Cardiovascular Complications of Vertically Transmitted HIV Infection
(P(2)C(2) HIV) Study Group. Cardiovascular status of infants and
children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study.
Lancet 2002; 360: 368–373.
9. Gopal M, Bhaskaran A, Khalife WI, Barbagelata A. Heart disease in
patients with HIV/AIDS – an emerging clinical problem. Curr Cardiol
Rev 2009; 5: 149–154.
10. Nzuobontane D, Blackett KN, Kuaban C. Cardiac involvement in
HIV infected people in Yaounde, Cameroon. Postgrad Med J 2002; 78:
678–681.
11. Starc TJ, Lipshultz SE, Kaplan S, et al. Cardiac complications in
children with human immunodeficiency virus infection. Pediatric
Pulmonary and Cardiac Complications of Vertically Transmitted HIV
Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood
Institute. Pediatrics 1999; 104: e14.
12. Brown SC, Schoeman CJ, Bester CJ. Cardiac findings in children
admitted to a hospital general ward in South Africa: a comparison of
HIV-infected and uninfected children. Cardiovasc J Sth Afr 2005; 16:
206–210.
13. Okoromah CA, Ojo OO, Ogunkunle OO. Cardiovascular dysfunction
in HIV-infected children in a sub-Saharan African country: compara-
tive cross-sectional observational study. J Trop Pediatr 2012; 58: 3–11.
14. Lipshultz SE, Williams PL, Wilkinson JD, et al. Pediatric HIV/AIDS
Cohort Study (PHACS). Cardiac status of children infected with human
immunodeficiency virus who are receiving long-term combination
antiretroviral therapy: results from the Adolescent Master Protocol of
the Multicenter Pediatric HIV/AIDS Cohort Study. J Am Med Assoc
Pediatr 2013; 167: 520–527.
15. Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart
S. Contribution of the human immunodeficiency virus/acquired immu-
nodeficiency syndrome epidemic to de novo presentations of heart
disease in the Heart of Soweto Study cohort. Eur Heart J 2012; 33:
866–874.
16. Lubega S, Zirembuzi GW, Lwabi P. Heart diseases among children with
HIV/AIDS attending the pediatric infectious disease clinic at Mulago
hospital. Afr Health Sci 2005; 5: 19-26.
17. National guidelines for comprehensive HIV prevention, care and treat-
ment. Addis Ababa: Ministry of Health, 2018.
18. Rajeshwari K, Amritsinh SP, Mandal RN, Kurian S, Anuradha S.
Cardiac abnormalities in HIV infected children presenting to a tertiary
level teaching hospital at New Delhi. Br J Med Med Res 2014; 4:
237–243.
19. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis
and treatmentof pulmonary hypertension: The Task Force for the
Diagnosis and Treatment of Pulmonary Hypertension of the European
Society of Cardiology (ESC) and the European Respiratory Society
(ERS), endorsed by the International Society of Heart and Lung
Transplantation (ISHLT). Eur Heart J 2009; 30: 2493–2537.
20. Augustine DX, Coates-Bradshaw LD, Willis J, et al. Echocardiographic
assessment of pulmonary hypertension: a guideline protocol from the
British Society of Echocardiography. Echo Res Pract 2018; 5: G11–G24.
21. Weitzman LB, Tinker WP, Kronzon I, Cohen ML, Glassman E, Spencer
FC. The incidence and natural history of pericardial effusion after cardi-
ac surgery – an echocardiographic study. Circulation 1984; 69: 506–511.
22. Cho C-M. Myocardial mass and myocardial mass index calculator.
. Accessed December 2018.
23. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac
chamber quantification by echocardiography in adults: an update
from the American Society of Echocardiography and the European
Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;
28: 1–39.
24. Lang RM, Bierig M, Devereux RB, et al. Recommendations for
chamber quantification: a report from the American Society of
Echocardiography’s Guidelines and Standards Committee and the
Chamber Quantification Writing Group, developed in conjunction
with the European Association of Echocardiography, a branch of the
European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:
1440–1463.
25. Myung KP. Special tools in evaluation of cardiac patients (non-invasive
techniques): echocardiography. In Pediatric Cardiology for Practitioners .
5th edn. Philadelphia: Mosby Elsevier, 2005: 200.
26. Eidem BW, McMahon CJ, Cohen RR, et al . Impact of cardiac growth
on Doppler tissue imaging velocities: a study in healthy children. J Am
Soc Echocardiogr 2004; 17: 212–221.
27. Sims A, Frank L, Cross R, et al. Abnormal cardiac strain in children
and young adults with HIV acquired in early life. J Am Soc Echocardiogr
2012; 25: 741–748.
28. Lipshultz SE, Williams PL, Wilkinson JD, et al. Cardiac status of
children infected with human immunodeficiency virus who are receiv-
ing long-term combination antiretroviral therapy: results from the
Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS
Cohort Study. J Am Med Assoc Pediatr 2013; 167: 520–527.
29. Lipshultz SE, Shearer WT, Thompson B, et al. Antiretroviral therapy
(ART) cardiac effects in HIV-infected children: the multicenter NHLBI
Cardiac Highly Active Antiretroviral Therapy (CHAART-II) study.
Circulation 2009; 120: S909–S910.
30. Pugliese A, Isnardi D, Saini A, Scarabelli T, Raddino R, Torre D. Impact
of highly active antiretroviral therapy in HIV-positive patients with
cardiac involvement. J Infect Dis 2000; 40: 282–284.
31. Plebani A, Esposito S, Pinzani R, et al. Effect of highly active antiret-
roviral therapy on cardiovascular involvement in children with human
immunodeficiency virus infection. Pediatr Infect Dis J 2004; 23: 559–563.
32. Karavidas A, Tsiachris D, Lazaros G, et al . Doppler tissue imaging
unmasks right ventricular function abnormalities in HIV-infected
patients. Cardiol J 2010; 17: 587–593.
33. Suran D, Sinkovic A, Naji F. Tissue Doppler imaging is a sensitive
echocardiographic technique to detect subclinical systolic and dias-
tolic dysfunction of both ventricles in type 1 diabetes mellitus. BMC
Cardiovasc Disord 2016; 16: 72.
34. Eidem BW, Sapp BG, Suarez CR, Cetta F. Usefulness of the myocardial
performance index for early detection of anthracycline-induced cardio-
toxicity in children. Am J Cardiol 2001; 87: 1120–1122.
35. Karatzis EN, Giannakopoulou AT, Papadakis JE, Karazachos AV,
Nearchou NS. Myocardial performance index (Tei index): evaluating its
application to myocardial infarction. Hellenic J Cardiol 2009; 50: 60–65.
36. Cantinotti M, Giordano R, Scalese M, et al. Nomograms for mitral
inflow Doppler and tissue Doppler velocities in Caucasian children.
Cardiology 2016; 68: 288–289.
37. Cantinotti M, Lopez L. Nomograms for blood flow and tissue Doppler
velocities to evaluate diastolic function in children: a critical review. J
Am Soc Echocardiogr 2013; 26: 126–141.
38. 38. Pongprot Y, Sittiwangkul R, Silvilairat S, Sirisanthana V. Cardiac
manifestations in HIV-infected Thai children. Ann Trop Paediatr 2004;
24: 153–159.